Pseudomonas aeruginosa produces serious chronic infections in hospitalized patients and immunocompromised individuals, including patients with cystic fibrosis. The molecular mechanisms by which P . aeruginosa responds to antibiotics and other stresses to promote persistent infections may provide new avenues for therapeutic intervention. Azithromycin (AZM), an antibiotic frequently used in cystic fibrosis treatment, is thought to improve clinical outcomes through a number of mechanisms including impaired biofilm growth and quorum sensing (QS). The mechanisms underlying the transcriptional response to AZM remain unclear. Here, we interrogated the P . aeruginosa transcriptional response to AZM using a fast, cost-effective genome-wide approach to quantitate RNA 3’ ends (3pMap). We also identified hundreds of P . aeruginosa genes with high incidence of premature 3’ end formation indicative of riboregulation in their transcript leaders using 3pMap. AZM treatment of planktonic and biofilm cultures alters the expression of hundreds of genes, including those involved in QS, biofilm formation, and virulence. Strikingly, most genes downregulated by AZM in biofilms had increased levels of intragenic 3’ ends indicating premature transcription termination, transcriptional pausing, or accumulation of stable intermediates resulting from the action of nucleases. Reciprocally, AZM reduced premature intragenic 3’ end termini in many upregulated genes. Most notably, reduced termination accompanied robust induction of obgE , a GTPase involved in persister formation in P . aeruginosa . Our results support a model in which AZM-induced changes in 3’ end formation alter the expression of central regulators which in turn impairs the expression of QS, biofilm formation and stress response genes, while upregulating genes associated with persistence. Author summary Pseudomonas aeruginosa is a common source of hospital-acquired infections and causes prolonged illness in patients with cystic fibrosis. P . aeruginosa infections are often treated with the macrolide antibiotic azithromycin, which changes the expression of many genes involved in infection. By examining such expression changes at nucleotide resolution, we found azithromycin treatment alters the locations of mRNA 3’ ends suggesting most downregulated genes are subject to premature 3’ end formation. We further identified candidate RNA regulatory elements that P . aeruginosa may use to control gene expression. Our work provides new insights in P . aeruginosa gene regulation and its response to antibiotics.
【초록키워드】 Treatment, Gene Expression, Azithromycin, Macrolide, Stress, Transcription, Infection, fibrosis, Antibiotics, hospitalized patients, molecular mechanism, clinical outcomes, RNA, Culture, persistence, mRNA, Patient, Premature, Gene regulation, stress response, cystic fibrosis, incidence, virulence, expression, change, mechanism, antibiotic, nucleotide, Hospital-acquired infection, Pseudomonas aeruginosa, chronic infection, Support, Regulation, control gene, hospital-acquired infections, immunocompromised individuals, subject, growth, accumulation, azithromycin treatment, molecular mechanisms, therapeutic intervention, 3’ end, transcriptional response, upregulated genes, quorum, GTPase, chronic infections, nucleases, planktonic, MOST, transcript, Genes, Alter, approach, transcriptional, robust, thought, resulting, involved, reduced, treated, provide, changes in, hospitalized patient, promote, cause, respond, turn, impair, downregulated, regulatory element, upregulating, accompanied, downregulated gene, improve clinical outcome, P . aeruginosa, 【제목키워드】 mRNA, Premature, 3’ end, reveal,